Avid Bioservices, Inc. (CDMO)

Avid Bioservices Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2024	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Cash & Equivalents	33.42	38.11	38.54	126.17	169.92	36.26
Short-Term Investments	1.7	4.4	-	-	-	-
Cash & Short-Term Investments	35.12	42.51	38.54	126.17	169.92	36.26
Cash Growth	11.75%	10.28%	-69.45%	-25.75%	368.58%	12.09%
Accounts Receivable	30.21	29.01	27.91	25.92	24.95	11.91
Receivables	30.21	29.01	27.91	25.92	24.95	11.91
Inventory	28.07	30.38	43.91	26.06	11.87	10.88
Prepaid Expenses	3.1	2.11	2.09	1.88	1.06	0.71
Total Current Assets	96.51	104	112.45	180.02	207.8	59.76
Property, Plant & Equipment	222.57	227.67	220.54	129.76	56.15	47.21
Other Intangible Assets	-	-	-	-	0.9	-
Long-Term Deferred Tax Assets	-	-	113.75	115.08	-	-
Other Long-Term Assets	4.41	4.88	4.82	4.98	0.66	0.65
Total Assets	323.48	336.56	451.57	429.84	265.51	107.62
Accounts Payable	9.25	20.67	24.59	9.5	9.26	5.93
Accrued Expenses	8.22	5.44	8.78	8.42	8.79	3.02
Short-Term Debt	-	-	-	-	-	4.38
Current Portion of Long-Term Debt	-	-	140.62	-	-	-
Current Portion of Leases	2.94	2.8	1.89	3.47	1.36	1.23
Current Unearned Revenue	51.67	39.89	37.35	53.8	50.77	29.12
Other Current Liabilities	2.07	1.77	1.91	0.57	0.76	0.81
Total Current Liabilities	74.16	70.57	215.15	75.76	70.94	44.48
Long-Term Debt	154.15	153.59	-	139.58	96.95	-
Long-Term Leases	49.93	51.44	47.25	39.98	19.89	21.24
Long-Term Deferred Tax Liabilities	-	0.07	-	-	-	-
Other Long-Term Liabilities	0.44	-	-	-	-	-
Total Liabilities	278.67	275.67	262.4	255.32	187.77	65.72
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06
Additional Paid-In Capital	639.56	632.7	620.22	605.84	637.53	612.91
Retained Earnings	-594.81	-571.87	-431.12	-431.38	-559.86	-571.07
Total Common Equity	44.81	60.89	189.17	174.53	77.74	41.89
Shareholders' Equity	44.81	60.89	189.17	174.53	77.74	41.9
Total Liabilities & Equity	323.48	336.56	451.57	429.84	265.51	107.62
Total Debt	207.02	207.83	189.76	183.03	118.19	26.85
Net Cash (Debt)	-171.91	-165.33	-151.22	-56.86	51.72	9.41
Net Cash Growth	-	-	-	-	449.59%	-70.83%
Net Cash Per Share	-2.70	-2.62	-2.37	-0.81	0.87	0.17
Filing Date Shares Outstanding	63.96	63.58	62.73	61.83	61.1	56.51
Total Common Shares Outstanding	63.96	63.57	62.69	61.81	61.07	56.48
Working Capital	22.35	33.44	-102.7	104.26	136.87	15.28
Book Value Per Share	0.70	0.96	3.02	2.82	1.27	0.74
Tangible Book Value	44.81	60.89	189.17	174.53	76.84	41.89
Tangible Book Value Per Share	0.70	0.96	3.02	2.82	1.26	0.74
Machinery	50.62	47.46	42.21	36.26	27.18	21.05
Construction In Progress	21.63	72.5	68.41	43.81	8.37	2.56
Leasehold Improvements	153.36	103.18	97.51	37.35	23	21.13
Order Backlog	-	177.3	157.3	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q